News | Mammography | September 30, 2015

Volpara Showcases Breast Density Assessment and Analytics Tools at RSNA

Volpara, breast density fiber glandular density

September 30, 2015 — Volpara Solutions will be showcasing the latest updates on its breast density and quantitative breast imaging capabilities at booth (South Hall - 2377), including:

•    VolparaDensity – the latest version of VolparaDensity, the benchmark in breast density assessment and clinically proven versus sensitivity of mammography and risk of developing cancer. RSNA updates include configurable breast density scorecards, a high capability server and and the ability to route patient results by Volpara’s FDA cleared Volpara Density Grades (VDG), analogous to the BI-RADS density categories. 

•    VolparaAnalytics v1.2 – Featuring a re-designed user interface and reporting features, VolparaAnalytics v1.2 also delivers expanded breast imaging metrics to users, including new temporal analysis tools, additional tools to analyze patient positioning and patient-dose, and time between study acquisitions.

•    RSNA Presentations: Volpara and Volumetrics Related Research – The ability of volumetric breast density, patient-specific mammographic dose and volumetric breast imaging metrics to provide critical insight for optimal breast imaging workflow is the focus of numerous studies being presented at RSNA, including:

- Quantifying the potential masking risk of breast density in mammographic screening, Dr Stamatia V. Destounis, M.D. 

- Volumetric breast density a strong independent predictor of interval cancer risk, Dr Stamatia V. Destounis, M.D.

- Volumetric breast density and mean glandular dose estimated from digital breast tomosynthesis projections and digital mammograms, Prof Kwan Ng  

•    Volpara Solutions’ complete suite of quantitative breast imaging tools: built to enable personalized measurements of volumetric breast density, patient-specific dose, breast compression and other factors to help breast imaging centers maintain accuracy and consistent quality in breast screening.  

- VolparaDensity: VolparaDensity is used by radiologists to objectively assess density from digital mammograms to help doctors evaluate which women would benefit from additional screening.  Highly correlated to 3D breast MR assessments, VolparaDensity is a reliable tool that automatically generates an objective measurement of volumetric breast density correlated to the ACR breast density categories.  To date, more than 7-million women have had their breast density analyzed using VolparaDensity.  

- VolparaAnalytics assists in quality assurance by monitoring critical elements of the breast imaging process and generating key metrics to help breast imaging centers monitor the performance of technologists, readers, and mammography and tomosynthesis machines. VolparaAnalytics provides unique information such as average pressure applied by each technologist, and breast density profiles by mammography system, helping address potential issues early.

- VolparaDose calculates mammography dose by using a standard mean glandular dose (MGD) algorithm along with patient-specific volumetric breast density to give a better estimate of the dose absorbed by the specific breast. The VolparaDose data can be inserted directly into patient letters on compatible mammography reporting systems, and sent to enterprise wide dose tracking systems.  

For more information: www.volparasolutions.com

Related Content

Theraclion to Launch Metastatic Breast Cancer Trial Combining Echotherapy and Immunotherapy
News | Focused Ultrasound Therapy | September 18, 2017
September 18, 2017 — Theraclion and co-lead investigator David Brenin, M.D., from the University of Virginia School o
DenseBreast-info.org Debuts  Spanish Language Video  About Dense Breasts
News | Breast Density | September 12, 2017
Breast cancer risks associated with breast density are the subject of a new Spanish language video launched recently by...
Asian Study Underlines Potential Value of Pressure-Guided Mammography
News | Mammography | September 11, 2017
Sigmascreening recently announced that a study of in total 15,898 in digital mammograms from 3,772 Asian women...
Delphinus Enrolls First Patient in Discover Breast Ultrasound Clinical Project
News | Ultrasound Womens Healthcare | September 08, 2017
September 8, 2017 — Delphinus Medical Technologies Inc.
Breast imaging X-ray mammogram showing a breast tumor. Photo courtesy of Monthian Ritchan-Ad

Photo courtesy of Monthian Ritchan-Ad

Feature | Breast Density | September 08, 2017 | By Roy Prager, M.D.
While mammograms play a vital role in efforts to identify breast cancer, they can present some challenges in women with...
FDA Clears Senographe Pristina Mammography System With Patient-Assisted Compression
Technology | Mammography | September 05, 2017
The U.S. Food and Drug Administration (FDA) cleared GE Healthcare’s Senographe Pristina with Self-Compression, the...
FDA Releases Six-Month Inspection Data From EQUIP Mammography Quality Initiative
News | Mammography | September 01, 2017
September 1, 2017 — The Division of Mammography Quality Standards (DMQS) of the U.S.
Hologic Announces Availability of Brevera Breast Biopsy System With CorLumina Imaging Technology
Technology | Breast Biopsy Systems | August 31, 2017
Hologic Inc. announced U.S. commercial availability of the Brevera breast biopsy system with CorLumina imaging...
China FDA Approves Xoft Axxent Balloon Applicators for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | August 30, 2017
iCAD Inc. announced that the company’s Xoft Axxent balloon applicators have received approval from the China Food...
Top list of stories, article, videos for breast imaging.
Feature | Breast Imaging | August 30, 2017 | Dave Fornell
August 30, 2017 — This is a list of the top breast imaging content so far for 2017.
Overlay Init